Don’t Miss: Concert Pharmaceuticals (NASDAQ:CNCE), Lloyds Banking Group plc (NYSE:LYG), Westell Technologies (NASDAQ:WSTL), Ambarella (NASDAQ:AMBA), Accuride Corp. (NYSE:ACW)

On Tuesday shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) closed at $14.54. On May 01, Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) announced that it will report its first quarter 2015 financial results on Friday, May 8, 2015 before the U.S. financial markets open.

Lloyds Banking Group plc (NYSE:LYG) in last trading activity moved down -0.20% to close at $5.11. Company weekly performance is 5.36% while its quarterly performance stands at 12.91%. Lloyds Banking Group plc (NYSE:LYG) is -6.18% away from its 52 week high. On May 01, Lloyds Banking Group Plc(NYSE:LYG) said it will exceed its lending profitability target and first-quarter earnings beat analyst estimates. Lloyds Chief Executive Officer Antonio Horta-Osorio returned the lender to its first profit in five years in 2014 after selling assets, shrinking the retail network and eliminating thousands of jobs. Chancellor George Osborne has recouped about 10 billion pounds selling Lloyds shares to institutional money managers and has pledged a sale to individual investors if re-elected in May 7 elections.

On last trading day Westell Technologies, Inc. (NASDAQ:WSTL) advanced 4.62% to close at $1.36. Its volatility for the week is 8.91% while volatility for the month is 6.34%. WSTL’s sales growth for past 5 years was -6.20% and its EPS growth for past 5 years was 18.90%. Westell Technologies, Inc. (NASDAQ:WSTL) monthly performance is 3.03%. On April 30, Westell Technologies, Inc. (NASDAQ:WSTL), announced that it will host its fiscal fourth quarter 2015 earnings conference call on Thursday, May 21, 2015 at 8:30 a.m. CDT (9:30 a.m. EDT).

Ambarella, Inc. (NASDAQ:AMBA) has 3.60% insider ownership while its institutional ownership stands at 51.90%. In last trading activity company’s stock closed at $72.52. Ambarella (NASDAQ:AMBA) was upgraded by equities researchers at Vetr from a “strong sell” rating to a “sell” rating in a research report issued on Tuesday. The firm currently has a $68.74 target price on the stock. Vetr‘s price target would indicate a potential downside of 5.21% from the company’s current price.

On last trading day Accuride Corp. (NYSE:ACW) moved down -1.74% to close at $3.95. Its volatility for the week is 5.52% while volatility for the month is 4.58%. ACW’s sales growth for past 5 years was 6.50% and its EPS growth for past 5 years was 74.30%. Accuride Corp. (NYSE:ACW) monthly performance is -18.22%. Accuride Corporation (NYSE:ACW), saw its loss narrow to $0.59 million, or $0.01 a share for the quarter ended Mar. 31, 2015. In the previous year period, the company reported a loss of $3.57 million, or $0.08 a share.

Leave a Reply

Your email address will not be published. Required fields are marked *

*